Humedix Co., Ltd. (200670.KQ) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	177.9B	170.1B	161.9B	152.3B	123.2B
Cost of Revenue	100.2B	92.3B	86.9B	81.9B	70.2B
Gross Profit	77.7B	77.8B	75.0B	70.4B	53.0B
Operating Expenses
R&D Expense	9.4B	9.4B	9.2B	9.8B	9.7B
SG&A Expense	12.2B	15.5B	12.2B	12.7B	9.2B
General & Admin Expense	(15.3B)	2.9B	2.5B	2.9B	2.5B
Selling & Marketing Expense	12.6B	12.6B	9.7B	9.8B	6.7B
Other Expenses	15.6B	10.5B	10.4B	10.5B	8.8B
Total Operating Expenses	37.1B	35.4B	31.9B	33.0B	27.8B
Cost and Expenses	137.4B	127.7B	118.7B	115.0B	98.0B
Operating Income (EBIT)	40.5B	42.3B	43.1B	37.3B	26.0B
Non-Operating
Interest Income	12.6B	4.2B	3.6B	2.8B	1.7B
Interest Expense	11.2B	59.5M	55.6M	1.4B	3.2B
Net Interest Income	1.4B	4.1B	3.5B	1.3B	(1.4B)
Other Non-Op Income/Expense	17.7B	21.4B	5.2B	(4.9B)	2.9B
Non-Operating Income (excl Interest)	(21.5B)	(21.5B)	(5.3B)	3.5B	(12.3B)
EBT (Pre-Tax Income)	58.2B	63.8B	48.4B	32.4B	29.0B
Income Tax Expense	12.3B	12.0B	9.1B	7.6B	7.8B
Bottom Line
Net Income	45.9B	51.8B	39.3B	24.8B	21.1B
Earnings from Cont. Ops	45.9B	51.8B	39.3B	24.8B	21.2B
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	45.9B	51.8B	39.3B	24.8B	21.1B
Per Share
Basic EPS	₩3,781	₩5,017	₩3,795	₩2,512	₩2,274
Diluted EPS	₩3,779	₩5,007	₩3,795	₩2,512	₩2,274
Revenue Per Share	₩16,063	₩15,143	₩15,753	₩15,412	₩13,282
Shares
Basic Shares Outstanding	11.1M	11.2M	10.3M	9.9M	9.3M
Diluted Shares Outstanding	11.1M	11.2M	10.3M	9.9M	9.3M
Profitability Metrics
EBITDA	50.3B	53.2B	59.9B	45.1B	49.0B
D&A	9.7B	10.9B	11.5B	11.3B	11.5B
EBIT	40.5B	42.3B	48.4B	33.9B	37.5B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026